Abbott Laboratories Share Price
Equities
ABT
US0028241000
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 101.44 USD | +1.02% |
|
-1.85% | -18.88% |
| 14/04 | ImmuCell Corporation Announces Board Changes | CI |
| 13/04 | Persian Gulf, Oil Outlooks Damp Wall Street Pre-Bell, Asia, Europe Off | MT |
| Capitalization | 18TCr 15TCr 14TCr 13TCr 24TCr 16,38400Cr 25TCr 1,61600Cr 63TCr 7,87100Cr 66TCr 65TCr 27,95000Cr | P/E ratio 2026 * |
24.8x | P/E ratio 2027 * | 21.5x |
|---|---|---|---|---|---|
| Enterprise value | 20TCr 17TCr 16TCr 15TCr 27TCr 18,57800Cr 28TCr 1,83200Cr 72TCr 8,92500Cr 75TCr 73TCr 31,69300Cr | EV / Sales 2026 * |
3.94x | EV / Sales 2027 * | 3.54x |
| Free-Float |
86.65% | Yield 2026 * |
2.5% | Yield 2027 * | 2.66% |
Last Transcript: Abbott Laboratories
| 1 day | +1.00% | ||
| 1 week | -1.85% | ||
| Current month | -1.00% | ||
| 1 month | -7.56% | ||
| 3 months | -17.72% | ||
| 6 months | -21.48% | ||
| Current year | -18.88% |
| 1 week | 99.05 |  | 103.32 |
| 1 month | 99.05 | | 111.86 |
| Current year | 99.05 | | 129.46 |
| 1 year | 99.05 | | 139.06 |
| 3 years | 89.67 | | 141.23 |
| 5 years | 89.67 | | 142.6 |
| 10 years | 36.76 | | 142.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 52 | 31/03/2020 |
Philip Boudreau
DFI | Director of Finance/CFO | 53 | 01/09/2023 |
Sabina Ewing
CIO | Chief Investment Officer | 51 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Alpern
BRD | Director/Board Member | 75 | 10/10/2008 |
Sally Blount
BRD | Director/Board Member | 64 | 09/12/2011 |
Nancy McKinstry
BRD | Director/Board Member | 67 | 09/12/2011 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +0.85% | 7.18% | 26 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.02% | -1.85% | -19.47% | -2.76% | 18TCr | |
| -1.34% | -1.84% | +5.65% | +5.97% | 11TCr | |
| -0.35% | -2.08% | +11.82% | +90.09% | 6.22TCr | |
| +2.14% | +4.43% | +91.52% | +108.90% | 6.21TCr | |
| -0.47% | -1.28% | -23.24% | -39.49% | 4.43TCr | |
| +0.50% | +8.34% | - | - | 3.87TCr | |
| -0.31% | -3.11% | -7.91% | -46.27% | 2.42TCr | |
| -0.29% | -0.42% | +1.38% | +19.11% | 2.21TCr | |
| +0.66% | +5.08% | +5.26% | -36.12% | 2.08TCr | |
| +1.46% | -1.00% | -19.39% | +12.96% | 2TCr | |
| Average | +0.31% | +2.48% | +5.07% | +12.49% | 5.84TCr | |
| Weighted average by Cap. | +0.30% | +1.64% | +3.96% | +17.66% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.06TCr 4.29TCr 3.95TCr 3.73TCr 6.96TCr 4,71200Cr 7.09TCr 46TCr 18TCr 2,26300Cr 19TCr 19TCr 8,03800Cr | 5.54TCr 4.7TCr 4.33TCr 4.09TCr 7.63TCr 5,16200Cr 7.77TCr 51TCr 20TCr 2,48000Cr 21TCr 20TCr 8,80500Cr |
| Net income | 709.1Cr 600.96Cr 553.55Cr 522.58Cr 975.74Cr 66TCr 993.4Cr 6.51TCr 2.55TCr 32TCr 2.66TCr 2.6TCr 1,12600Cr | 818.85Cr 693.98Cr 639.23Cr 603.46Cr 1.13TCr 76TCr 1.15TCr 7.52TCr 2.94TCr 37TCr 3.07TCr 3.01TCr 1,30000Cr |
| Net Debt | 2.36TCr 2TCr 1.84TCr 1.74TCr 3.24TCr 2,19400Cr 3.3TCr 22TCr 8.47TCr 1,05400Cr 8.84TCr 8.66TCr 3,74300Cr | 2.02TCr 1.72TCr 1.58TCr 1.49TCr 2.79TCr 1,88500Cr 2.84TCr 19TCr 7.27TCr 91TCr 7.6TCr 7.44TCr 3,21600Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/26/15 | 101.59 $ | +1.17% | 10,75,834 |
| 14/26/14 | 101.05 $ | +0.36% | 1,16,90,230 |
| 13/26/13 | 100.69 $ | +0.39% | 1,11,99,548 |
| 10/26/10 | 100.30 $ | -2.36% | 1,19,44,755 |
| 09/26/09 | 102.72 $ | -0.81% | 61,98,999 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ABT Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition